Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenue from awards and licenses $ 3,937,230 $ 36,143,568
Operating expenses:    
Research and development 98,267,213 89,604,790
General and administrative 28,480,250 23,643,357
Total operating expenses 126,747,463 113,248,147
Operating loss (122,810,233) (77,104,579)
Other income (expense), net:    
Other income (expense), net 13,270,211 4,581,838
Interest income (expense), net (1,028,359) 1,227,643
Change in fair value of derivative liability (251,000)
Foreign currency exchange gain (loss) (449,999) (158,620)
Other income, net 11,540,853 5,650,861
Net loss $ (111,269,380) $ (71,453,718)
Net loss per share, basic and diluted $ (1.42) $ (1.12)
Weighted average number of common shares outstanding, basic and diluted 78,133,289 63,899,184